BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
0.437
-0.016 (-3.44%)
Nov 7, 2024, 3:25 PM EST - Market open

BioLineRx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
3911528996027
Upgrade
Market Cap Growth
-50.81%304.79%-71.33%65.98%124.34%-46.88%
Upgrade
Enterprise Value
31102-1940477
Upgrade
Last Close Price
0.451.570.592.042.522.25
Upgrade
PE Ratio
--24.95-18.30-49.99-21.22-12.95
Upgrade
PS Ratio
2.8424.01----
Upgrade
PB Ratio
3.468.720.561.462.720.80
Upgrade
P/FCF Ratio
-1.59-5.07-1.08-4.20-2.58-1.17
Upgrade
P/OCF Ratio
-1.60-5.10-1.09-4.21-2.58-1.18
Upgrade
EV/Sales Ratio
1.8021.22----
Upgrade
EV/EBITDA Ratio
-0.96-2.420.65-1.68-2.12-0.27
Upgrade
EV/EBIT Ratio
-0.92-2.370.64-1.63-2.03-0.26
Upgrade
EV/FCF Ratio
-1.05-4.480.70-1.71-2.01-0.32
Upgrade
Debt / Equity Ratio
2.240.880.240.070.350.31
Upgrade
Debt / FCF Ratio
-1.03-0.51-0.47-0.20-0.33-0.46
Upgrade
Asset Turnover
0.280.07----
Upgrade
Quick Ratio
1.441.434.855.892.142.35
Upgrade
Current Ratio
1.611.534.875.912.152.36
Upgrade
Return on Equity (ROE)
-171.94%-189.23%-41.96%-60.04%-108.36%-68.13%
Upgrade
Return on Assets (ROA)
-35.23%-38.30%-23.10%-24.07%-28.42%-32.00%
Upgrade
Return on Capital (ROIC)
-54.52%-61.08%-26.82%-30.23%-38.97%-37.43%
Upgrade
Earnings Yield
-76.31%-52.59%-87.63%-27.24%-50.16%-95.39%
Upgrade
FCF Yield
-77.08%-19.72%-92.62%-23.83%-38.78%-85.22%
Upgrade
Buyback Yield / Dilution
-22.24%-24.47%-16.75%-162.19%-72.70%-34.82%
Upgrade
Total Shareholder Return
-22.24%-24.47%-16.75%-162.19%-72.70%-34.82%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.